<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04297137</url>
  </required_header>
  <id_info>
    <org_study_id>191023/A/09</org_study_id>
    <nct_id>NCT04297137</nct_id>
  </id_info>
  <brief_title>The Bioavailability of Multiple Novel, Sustainable, Non-animal Derived Protein Sources</brief_title>
  <acronym>NOVA</acronym>
  <official_title>Comparing the Bioavailability of the Sustainable, Non-animal Derived Protein Sources Mycoprotein, Spirulina, Chlorella, Pea and Lupin to Milk Protein in Healthy Older Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Exeter</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Exeter</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The progressive age-related loss of muscle mass is termed sarcopenia. Consequences of
      sarcopenia are, but not limited to, decreased muscle strength, frailty, and an increased risk
      for the development of chronic metabolic diseases. As such, sufficient dietary protein intake
      is required for skeletal muscle mass preservation. However, the production of animal-based
      protein sources, such as milk, is associated with a number of economic, environmental, and
      ethical issues. Accordingly, there is a need to develop sustainable dietary protein sources
      to support our nutrition. Mycoprotein, spirulina, chlorella, pea, and lupin are novel,
      sustainable, non-animal derived protein sources that may represent potential alternative
      protein sources. However, the efficacy of these sources to stimulate muscle mass growth is
      unknown.

      Therefore, the present study will investigate the postprandial bioavailability of
      mycoprotein, spirulina, chlorella, pea, and lupin protein when compared to the animal-derived
      milk protein. Briefly, 12 healthy older adults will visit the University for 6 separate test
      days, with each day lasting 6 hours. Participants will consume the one of the 6 protein
      drinks on each test day. Repeated blood sampling will be used to assess protein digestion and
      subsequent systemic amino acid appearance.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 12, 2019</start_date>
  <completion_date type="Anticipated">August 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma amino acid concentrations</measure>
    <time_frame>5 hours</time_frame>
    <description>Peak and total plasma amino acid concentrations following protein ingestion</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood glucose</measure>
    <time_frame>5 hours</time_frame>
    <description>The levels of glucose in the blood following protein ingestion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum insulin</measure>
    <time_frame>5 hours</time_frame>
    <description>The levels of insulin in blood serum following protein ingestion</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Healthy Aging</condition>
  <arm_group>
    <arm_group_label>Mycoprotein</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ingestion of 30 g mycoprotein drink</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Spirulina</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ingestion of 30 g spirulina protein drink</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Chlorella</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ingestion of 30 g chlorella protein drink</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pea</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ingestion of 30 g pea protein drink</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lupin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ingestion of 30 g lupin protein drink</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Milk</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ingestion of 30 g milk protein</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Protein ingestion</intervention_name>
    <description>Ingestion of various sustainable non-animal derived protein sources compared to animal-based milk protein.</description>
    <arm_group_label>Chlorella</arm_group_label>
    <arm_group_label>Lupin</arm_group_label>
    <arm_group_label>Milk</arm_group_label>
    <arm_group_label>Mycoprotein</arm_group_label>
    <arm_group_label>Pea</arm_group_label>
    <arm_group_label>Spirulina</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males and females 55 - 80 years of age.

          -  Body mass index between 18.5 - 30.

        Exclusion Criteria:

          -  Any diagnosed metabolic impairment (e.g. type 1 or 2 Diabetes).

          -  Any diagnosed cardiovascular disease or hypertension.

          -  Elevated blood pressure (&gt;150/90 mmHg) at the time of screening.

          -  Known pre-existing liver disease/condition.

          -  Any medication known to affect protein and/or amino acid metabolism.

          -  Allergy to mycoprotein/Quorn/edible fungi, edible algae, lupin/legumes, or milk.

          -  Smoking.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Benjamin T Wall, PhD</last_name>
    <phone>01392724774</phone>
    <email>B.T.Wall@exeter.ac.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ino van der Heijden, MSc</last_name>
    <email>iv234@exeter.ac.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Exeter</name>
      <address>
        <city>Exeter</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 3, 2020</study_first_submitted>
  <study_first_submitted_qc>March 4, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 5, 2020</study_first_posted>
  <last_update_submitted>March 4, 2020</last_update_submitted>
  <last_update_submitted_qc>March 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

